Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2019/06/21/penny-stock-picks-up-fda-nod

6/21/2019 9:53 AM

The shares of Ocular Therapeutix Inc (NASDAQ:OCUL) are making a comeback today, after the drugmaker announced that the Food and Drug Administration (FDA) approved the company's DEXTENZA to treat pat...

Glaucoma Drug's Flop Has OCUL Stock Spiraling

https://www.schaeffersresearch.com/content/news/2019/05/21/glaucoma-drugs-flop-has-ocul-stock-spiraling

5/21/2019 9:37 AM

Pharma stock Ocular Therapeutix Inc (NASDAQ:OCUL) is in hot water today, down 11% at $3.00 in early trading, and pacing for its worst day since Dec. 3. The stock is fresh off a new record low of $2.7...

Drug Stock In Focus After FDA Resubmission

https://www.schaeffersresearch.com/content/news/2018/06/29/drug-stock-in-focus-after-fda-resubmission

6/29/2018 10:10 AM

Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) are down 2.2% at $7.09 in early trading, after the company announced its New Drug Application (NDA) resubmission for its eye pain drug DEXTENZA, to the ...

3 Biotech Stocks Reacting to Guggenheim 'Buy' Ratings

https://www.schaeffersresearch.com/content/options/2017/10/24/3-biotech-stocks-reacting-to-guggenheim-%27buy%27-ratings

10/24/2017 3:51 PM

It's been a strong year for the biotech sector, with the SPDR S&P Biotech ETF (XBI) and Health Care Select Sector SPDR Fund (XLV) boasting year-to-date gains of 42% and 20%, respectively. Against this...

Twitter Taps a New Finance Chief as Amazon Makes Prime Day History

https://www.schaeffersresearch.com/content/news/2017/07/12/twitter-taps-a-new-finance-chief-as-amazon-makes-prime-day-history

7/12/2017 10:08 AM

U.S. stocks are higher this morning, as markets prepare for Fed Chair Janet Yellen's remarks. Among specific stocks on the move today are biotech Ocular Therapeutix Inc (NASDAQ:OCUL), social media s...

PEOPLE ALSO SEARCH FOR